Mark Jit

45.4k total citations · 7 hit papers
355 papers, 14.2k citations indexed

About

Mark Jit is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Mark Jit has authored 355 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Epidemiology, 125 papers in Health and 99 papers in Infectious Diseases. Recurrent topics in Mark Jit's work include Vaccine Coverage and Hesitancy (120 papers), Cervical Cancer and HPV Research (72 papers) and COVID-19 epidemiological studies (71 papers). Mark Jit is often cited by papers focused on Vaccine Coverage and Hesitancy (120 papers), Cervical Cancer and HPV Research (72 papers) and COVID-19 epidemiological studies (71 papers). Mark Jit collaborates with scholars based in United Kingdom, United States and Hong Kong. Mark Jit's co-authors include W. John Edmunds, Raymond Hutubessy, Marc Brisson, Philippe Beutels, Alex R. Cook, Kiesha Prem, Yot Teerawattananon, Jacco Wallinga, Stefania Salmaso and Niel Hens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Mark Jit

345 papers receiving 13.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases

2008 1.9k citations Mark Jit, Philippe Beutels et al. profile →
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

2021 821 citations Olivier J. Wouters, Yot Teerawattananon et al. profile →
Projecting social contact matrices in 152 countries using contact surveys and demographic data

2017 502 citations Kiesha Prem, Alex R. Cook et al. PLoS Computational Biology profile →
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories

2021 236 citations Yang Liu, Mark Jit et al. BMC Medicine profile →
COVID-19 vaccine challenges: What have we learned so far and what remains to be done?

2021 214 citations Mark Jit et al. profile →
Adjusting for Inflation and Currency Changes Within Health Economic Studies

2019 205 citations Hugo C. Turner, Yot Teerawattananon et al. profile →
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination

2024 39 citations Edwin van Leeuwen, Stefan Flasche et al. The Lancet Regional Health - Europe profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark Jit	7.0k	4.0k	3.9k	3.4k	1.7k	355	14.2k
C. Raina MacIntyre	5.6k 0.8×	4.2k 1.0×	2.6k 0.7×	2.3k 0.7×	1.1k 0.7×	563	16.0k
W. John Edmunds	6.8k 1.0×	4.6k 1.1×	5.5k 1.4×	1.9k 0.6×	1.4k 0.8×	226	14.7k
Lone Simonsen	11.5k 1.6×	5.4k 1.3×	5.0k 1.3×	1.6k 0.5×	723 0.4×	194	18.1k
Philippe Beutels	4.6k 0.7×	2.9k 0.7×	3.7k 1.0×	1.8k 0.5×	1.6k 0.9×	334	10.8k
Alison P. Galvani	4.4k 0.6×	5.4k 1.3×	4.9k 1.2×	1.7k 0.5×	1.0k 0.6×	284	14.0k
Hongjie Yu	4.7k 0.7×	5.7k 1.4×	5.2k 1.3×	1.6k 0.5×	2.0k 1.2×	436	16.3k
Cécile Viboud	14.1k 2.0×	7.7k 1.9×	10.7k 2.7×	1.7k 0.5×	2.3k 1.4×	281	26.8k
Niel Hens	4.6k 0.7×	2.8k 0.7×	4.0k 1.0×	1.4k 0.4×	860 0.5×	382	11.0k
Tom Jefferson	5.0k 0.7×	2.1k 0.5×	1.1k 0.3×	1.4k 0.4×	1.6k 1.0×	182	11.7k
Benjamin J. Cowling	10.7k 1.5×	10.1k 2.5×	9.1k 2.3×	2.4k 0.7×	2.3k 1.4×	711	29.5k

Countries citing papers authored by Mark Jit

Since Specialization

Citations

This map shows the geographic impact of Mark Jit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jit more than expected).

Fields of papers citing papers by Mark Jit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Jit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jit. The network helps show where Mark Jit may publish in the future.

Co-authorship network of co-authors of Mark Jit

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Jit. A scholar is included among the top collaborators of Mark Jit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Jit. Mark Jit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Turner, Hugo C., et al.. (2025). An Introduction to Costing and the Types of Costs Used within Health Economic Studies. PharmacoEconomics - Open. 9(6). 849–868.

Russell, Fiona M., et al.. (2024). Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination. Vaccines. 12(7). 767–767. 2 indexed citations

Sbarra, Alyssa N., Felicity T. Cutts, Han Fu, et al.. (2024). Evaluating Scope and Bias of Population-Level Measles Serosurveys: A Systematized Review and Bias Assessment. Vaccines. 12(6). 585–585. 3 indexed citations

Mahmud, Sarwat, Ranju Baral, Colin Sanderson, et al.. (2023). Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries. BMC Medicine. 21(1). 138–138. 13 indexed citations

Turner, Hugo C., Paul Revill, Waranya Rattanavipapong, et al.. (2023). Analyses of the return on investment of public health interventions: a scoping review and recommendations for future studies. BMJ Global Health. 8(8). e012798–e012798. 9 indexed citations

Waterlow, Naomi R., Jeanette Dawa, Edwin van Leeuwen, et al.. (2023). Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study. BMC Medicine. 21(1). 106–106. 9 indexed citations

Divala, Titus, Andrés G. Lescano, Mohammed Majam, et al.. (2023). “We usually see a lot of delay in terms of coming for or seeking care”: an expert consultation on COVID testing and care pathways in seven low- and middle-income countries. BMC Health Services Research. 23(1). 1288–1288. 3 indexed citations

Portnoy, Allison, Rebecca A. Clark, Chathika K. Weerasuriya, et al.. (2023). The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries. BMJ Global Health. 8(7). e012466–e012466. 10 indexed citations

Tildesley, Michael J., Anna Vassall, Steven Riley, et al.. (2022). Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study. Royal Society Open Science. 9(8). 211746–211746. 14 indexed citations

10.

Zhao, Xuelian, Shangying Hu, Meng Gao, et al.. (2022). Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: a modelling study. EClinicalMedicine. 56. 101789–101789. 12 indexed citations

11.

Fu, Han, Kaja Abbas, Petra Klepac, et al.. (2021). Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries. BMC Medicine. 19(1). 11 indexed citations

12.

Portnoy, Allison, Kaja Abbas, Steven Sweet, Jane J. Kim, & Mark Jit. (2021). Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study. BMJ Global Health. 6(11). e006940–e006940. 12 indexed citations

13.

Prem, Kiesha, Kevin van Zandvoort, Petra Klepac, et al.. (2021). Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era. PLoS Computational Biology. 17(7). e1009098–e1009098. 122 indexed citations

14.

Liu, Di, Kathy Leung, Mark Jit, & Joseph T. Wu. (2021). Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities. Vaccine. 39(39). 5490–5498. 7 indexed citations

15.

Jombart, Thibaut, Quentin J. Leclerc, Mark Jit, et al.. (2021). Real-time monitoring of COVID-19 dynamics using automated trend fitting and anomaly detection. Philosophical Transactions of the Royal Society B Biological Sciences. 376(1829). 20200266–20200266. 12 indexed citations

16.

Jit, Mark, et al.. (2021). Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic. The Lancet Regional Health - Europe. 9. 100221–100221. 56 indexed citations

17.

Gilson, Richard, Diarmuid Nugent, Kate Bennett, et al.. (2020). Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. Health Technology Assessment. 24(47). 1–86. 21 indexed citations

18.

Prudden, H, Mateusz Hasso-Agopsowicz, Robert E. Black, et al.. (2020). Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28–29th November 2018. Vaccine. 38(31). 4792–4800. 15 indexed citations

19.

Verguet, Stéphane, Mira Johri, Shaun K. Morris, et al.. (2014). Controlling measles using supplemental immunization activities: A mathematical model to inform optimal policy. Vaccine. 33(10). 1291–1296. 60 indexed citations

20.

Hoek, Albert Jan van, Anthony Underwood, Mark Jit, Elizabeth Miller, & W. John Edmunds. (2011). The Impact of Pandemic Influenza H1N1 on Health-Related Quality of Life: A Prospective Population-Based Study. PLoS ONE. 6(3). e17030–e17030. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact